Roger W. Louis
No más puestos en curso
Perfil
Roger W.
Louis worked as a Chief Compliance Officer & Senior Vice President at Biogen, Inc. and Genzyme Corp.
He also held the same position at Cubist Pharmaceuticals LLC and Novelion Therapeutics, Inc. Additionally, he worked as the Global Chief Compliance Officer & Senior VP at Aegerion Pharmaceuticals, Inc. and as Chief Counsel at Blue Cross & Blue Shield of Massachusetts, Inc. Prior to his career in compliance, he worked as an Associate at Hale & Dorr LLP.
Louis received his undergraduate degree from Tufts University and his graduate degree from The University of Chicago Law School.
Antiguos cargos conocidos de Roger W. Louis.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Compliance Officer | 24/09/2019 |
| AEGERION PHARMACEUTICALS, INC. | Compliance Officer | 01/11/2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Compliance Officer | 01/01/2012 |
| BIOGEN INC. | Compliance Officer | 01/01/2012 |
| CUBIST PHARMACEUTICALS INC | Compliance Officer | - |
Formación de Roger W. Louis.
| Tufts University | Undergraduate Degree |
| The University of Chicago Law School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Blue Cross & Blue Shield of Massachusetts, Inc.
 Blue Cross & Blue Shield of Massachusetts, Inc. Miscellaneous Commercial ServicesCommercial Services Blue Cross & Blue Shield of Massachusetts, Inc. provides indemnity insurance and medicare extension programs. The firm offers medical and dental plans, pharmacy coverage, vision coverage and health savings accounts. The company was founded in 1937 and is located in Boston, MA. | Commercial Services |
| Hale & Dorr LLP | Commercial Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Roger W. Louis
